Additionally, while the findings indicate an association of IgG-Fn positivity with NAT resistance as well as prognosis in ESCC cases, they do not provide direct experimental or functional validation to establish a causal relationship, and further investigations will be required to elucidate the precise biological mechanisms. The gene discussed is BRD2; the disease is esophageal squamous cell carcinoma.